Glaucoma Today

09/04/2025

Neeru A. Vallabh, MBBS, FRCOphth, PhD, FEBOS-GL, recaps her article, “The Role of Anterior Segment OCT in MIGS,” which was featured in the March/April issue of Glaucoma Today.

Dr. Vallabh explores how this mode of advanced imaging can enhance the patient evaluation and surgical results, reviewing its utility for preoperative evaluation and intraoperative adjustments and its ability to provide insights into postoperative outcomes: https://ow.ly/auUI50WR9Hh

09/03/2025

Join experts Drs. Sarah Van Tassel and Anu Laul for a live webinar on the crucial interplay between structural and functional changes in glaucoma. Learn strategies for interpreting HFA results and monitoring disease progression. 📅 Sept 23 | 8 PM ET / 5 PM PT 👉 Reserve your spot today! https://ow.ly/YtVZ50WQj8m

08/27/2025

"Pediatric angle-closure glaucoma (ACG) is a rare but serious condition that may be associated with ocular or developmental anomalies.

Although open-angle glaucoma is a more common cause of elevated IOP in the pediatric population, clinicians should maintain a high index of suspicion for angle closure because of its potential to cause severe visual impairment and its unique management.

This article reviews causes of angle closure that should be considered in any child presenting with elevated IOP" - Benjamin Katz, MD, and Andrew R. Lee, MD

Continue reading here: https://ow.ly/1JLF50WN8xh

08/22/2025

A surgical case by Arkadiy Yadgarov, MD:

"A 71-year-old man presented for a routine glaucoma follow-up. He was phakic with 20/25 best-corrected visual acuity (BCVA) in both eyes, though central vacuoles were noted. On a prior visit, glare testing reduced his vision to 20/40, but he declined cataract surgery, stating he was satisfied with his vision. MIGS was not discussed at that time. He was diagnosed with moderate primary open-angle glaucoma (POAG) in both eyes, with an intraocular pressure (IOP) of 16 mmHg OU and a historical maximum of 23 mmHg. Central corneal thickness measured 510 microns OU. The patient was using latanoprost QHS and timolol QAM; however, his adherence was estimated at just 60–70%.

During the visit, his comments revealed troubling compliance issues. He shared, “I do miss a dose here and there,” “It takes many tries to get one drop in,” and “I often run out of the bottle early.” These admissions raised red flags, considering the strong correlation between poor adherence and glaucoma progression. With this in mind, I opted for a proactive treatment approach rather than waiting for further visual field or lens changes. I discussed the benefits of combining cataract extraction with MIGS—specifically canaloplasty and trabeculotomy using the OMNI® Edge Surgical System—to improve natural outflow and reduce reliance on topical medications. Once he understood the potential for better glaucoma control and a reduced medication burden, he was enthusiastic about moving forward.

After undergoing the OMNI procedure, the patient was pleased with his controlled IOP and appreciated not having to rely solely on medications for glaucoma management."

See the full discussion of this case here: https://ow.ly/GS0150WJyiE

__________

OMNI Edge is indicated for followed by to reduce intraocular pressure in adult patients with primary open-angle . Please visit https://ow.ly/AO0V50WJyiA for more information and for the full instructions or use, warnings, precautions, and adverse event information."

08/21/2025

Watch as experts review how standalone MIGS with the OMNI® Surgical System offers the potential to expand the number of patients who can benefit from procedural options for primary open-angle glaucoma treatment: https://ow.ly/oFqx50WJFEa

Visit https://ow.ly/xoHO50WJFE9 to see the indications for use, contraindications, warnings, and potential adverse events.

08/14/2025

Children may be the most vulnerable group that glaucoma specialists treat. Most cases of pediatric glaucoma are managed surgically, typically first with angle-based procedures. Glaucoma surgery on a pediatric patient, however, is not the same as glaucoma surgery on an adult.

The small size and anatomy of children’s eyes warrant special consideration. More time and patience are needed for evaluation, decision-making, and family education on the disease, treatment options, and lifelong follow-up required.

This article from Zeynep Aktas, MD, FEBO, FGS, and Ahmet Yucel Ucgul, MD, FRCS, FICO, FEBO shares pearls for successful pediatric angle surgery, including some useful tips for the pre- and postoperative periods: https://ow.ly/4EWT50WGanc

08/13/2025

Thank you to the outstanding faculty, guests, and industry partners who made MIGS Unplugged Live an inspiring success. Your expertise, curiosity, and collaboration brought the latest in minimally invasive glaucoma surgery to life. We’re grateful for your contributions and look forward to continuing the conversation together: https://ow.ly/gmGt50WFyvS

08/12/2025

CASE PRESENTATION: A 55-year-old man presents for an evaluation. The patient reports having blurry vision and episodes of elevated IOP in the right eye since undergoing cataract surgery 4 months ago. Uncomplicated cataract surgery was performed on the left eye 2 weeks after the procedure on the right eye.

A Light Adjustable Lens (RxSight) was implanted in each eye, but the postoperative light treatments have been delayed owing to the problems in the right eye. Continue reading this article from Glaucoma Today here: https://ow.ly/nMkY50WEVLv

08/08/2025

Pediatric glaucoma can be a devastating and challenging disease for both patients and ophthalmologists.

Yet, in our experience, it is also among the most rewarding conditions to treat. Remarkably, it may be the only form of glaucoma with the potential for a true cure.

Read more in the latest edition of Glaucoma Today: “Pediatric Glaucoma” at GlaucomaToday.com.

08/06/2025

Want to increase your MIGS efficiency?

Christine M. Funke, MD shares intraoperative pearls that can make the difference between stent placement and stent performance. From visualization tips to flow confirmation, this quick read delivers technique-driven insights:

Keys to proper visualization and device placement.

08/05/2025

Andrew Tatham, MD, MBA, FRCOphth, FEBO, CertLRS, recaps his article, “A Cilioscleral Interpositioning Device,” which was featured in the March/April issue of Glaucoma Today and explores a novel class of glaucoma surgery that targets the supraciliary space.

The Intercil Uveal Spacer from Ciliatech represents this new class of surgical implants known as cilioscleral interpositioning devices, or CIDs, which enhance uveoscleral outflow to lower IOP: https://ow.ly/UnxL50WA9Zq

07/31/2025

In an emergent setting, minutes matter. Are you confident in your approach to managing acute angle-closure glaucoma?

This article walks through a stepwise strategy for rapid assessment and intervention—highlighting key clinical signs, initial treatment priorities, and considerations for definitive management:

Glaucoma specialists from different hospitals describe their approaches.